All posts by Alex Hughes

An update on Supplementary Protection Certificates in Europe

An update on Supplementary Protection Certificates in Europe

European Commission proposes changes to Supplementary Protection Certificates Supplementary Protection Certificates (SPCs) are an intellectual property right that serve as an extension to a patent right (for up to five years) specific to pharmaceutical and plant products that must undergo extensive testing and clinical trials before being authorised by marketing authorities in Europe. Earlier in 2018,… Read more »

The year in review: AA Thornton on Battery Technology

The year in review: AA Thornton on Battery Technology

 AA Thornton reflect on the past year in the battery and energy storage industries On the 4th and 5th of December, Patent Attorneys Marianne Privett and David Blair attended the ‘Battery and Energy Storage Show 2018’ hosted by Warwick University (with Matt Havron joining them on the 5th December). At the event, Marianne and David… Read more »

EUIPO’s Board of Appeal pharmaceutical decision

EUIPO’s Board of Appeal pharmaceutical decision

Suzanne Power reports on recent EUIPO Board of Appeal case – Nikken International, Inc. v Takeda Pharmaceutical Company Limited Trade Mark Associate Suzanne Power recently contributed to the December edition of the Pharmaceutical Trade Mark Group’s Law, Lore & Practice publication. Suzanne reports on a recent decision from the EUIPO’s Board of Appeal regarding preparations used… Read more »

Brexit update – December 2018

Brexit update – December 2018

EU Trade Marks and Community Designs – Deal, no deal, or no Brexit at all? What is the current situation? Considerable doubt remains about how, when or even if the UK will leave the EU. However, if the UK leaves without a deal then the outcome in relation to IP should be essentially the same… Read more »

RACETECH: The problem of counterfeiting in Motorsport

RACETECH: The problem of counterfeiting in Motorsport

Fake News! The problem of counterfeiting in Motorsport Partner Alex Bone and Associate Patent Attorney, Stuart Greenwood recently wrote an article for the December / January issue of RACETECH magazine. Their article ‘Fake News!’ discussed how fake goods are increasingly a problem in the motorsport industry and offered advice on how to counter the counterfeiters…. Read more »

IP Inclusive Week at AA Thornton

IP Inclusive Week at AA Thornton

AA Thornton celebrates IP Inclusive Week AA Thornton took part in the celebration of IP Inclusive Week, to showcase the importance of diversity and inclusion in the IP professions. At the start of the week, IP Inclusive launched a pack for running a work experience day, making it easy for firms to invite students to… Read more »

Mike Jennings Chairs AI patenting panel at CIPA’s Computers and IP Conference

Mike Jennings Chairs AI patenting panel at CIPA’s Computers and IP Conference

Patenting Artificial Intelligence – CIPA’s Computer Technology Committee Training CIPA’s Computer Technology Committee provided an excellent update on ‘Computers and IP’ on 22 November in London, including contributions from AA Thornton partner Mike Jennings who chaired a panel discussing patentability of artificial intelligence. The panel focussed on the many technical applications of machine learning and… Read more »

BioScience Today – Patenting aerospace medicines

BioScience Today – Patenting aerospace medicines

Patenting aerospace medicines – the final frontier? Consulting Attorney, Julie Barrett-Major recently wrote for BioScience Today on the subject of Patenting aerospace medicines. You can find Julie’s article below, or read the full magazine here.  Should you wish to discuss this topic, please contact the author, Julie Barrett-Major, or your usual AA Thornton contact.

Landmark UK Supreme Court Judgment in Warner Lambert v Generics (Mylan) & Actavis (Pregabalin / Lyrica)

Landmark UK Supreme Court Judgment in Warner Lambert v Generics (Mylan) & Actavis (Pregabalin / Lyrica)

Sufficiency and Infringement of Second Medical Use Patents Landmark UK Supreme Court Judgment in Warner Lambert v Generics (Mylan) & Actavis (Pregabalin/Lyrica) The Supreme Court of the United Kingdom has now released their long-awaited decision relating to the tests for sufficiency and infringement for second medical use patents, in particular those with so-called “Swiss-form” claims… Read more »

Mike Jennings attends EPO’s AI Conference

Mike Jennings attends EPO’s AI Conference

Commenting on the EPO’s AI discussions Partner Mike Jennings attended the EPO’s AI conference on 30 May, commenting:  “The EPO deserves praise for investing in an excellent discussion with industry and members of the judiciary about the future for AI patenting. The 30 May 2018 conference was part of that discussion. The consultation provided a good… Read more »

Categories

Archives